Background: Hypoxia is an important risk factor for development of necrotizing enterocolitis (NEC) in premature infants. Hypoxia-inducible factor (HIF)-1 is a transcription factor that plays a critical role in cellular responses to hypoxia and can be induced by phosphatidylinositol 3-kinase (PI3-K) pathway. Activation of the PI3-K and regulation of HIF-1 during NEC have not been elucidated. Methods: NEC was induced in 3-day-old neonatal mice using hypoxia and artificial formula feedings. Mice were divided into 3 treatment groups: (1) NEC alone, (2) NEC with insulin-like growth factor (IGF)-I, or (3) NEC with Akt1 siRNA treatment. Animals were sacrificed, and intestinal sections were harvested for protein analysis, H&E, and immunohistochemical staining. Results: In vivo model of NEC produced intestinal injury associated with increased protein expression of HIF-1α, pAkt, PARP, and caspase-3 cleavage. Pretreatment with IGF-1 attenuated an HIF-1α response. In contrast, targeted inhibition of Akt1 completely abolished NEC-induced expression of pAkt and upregulated HIF-1α activation. Conclusions: NEC activates important protective cellular responses to hypoxic injury such as HIF-1α and PI3-K/Akt in neonatal gut. Hypoxia-mediated activation of pro-survival signaling during NEC may be modulated with growth factors, which thus suggests a potential therapeutic option in the treatment of neonates with NEC.
|Number of pages||8|
|State||Published - Aug 2007|
Bibliographical noteFunding Information:
Supported by grants RO1 DK61470, RO1 DK48498, and PO1 DK35608 from the National Institutes of Health and Grant 8580 from Shriners Burns Hospital.
ASJC Scopus subject areas